Home -
Products -
Others -
Other Targets -
Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s)
Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s)
CAS No. 9004-32-4
Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s)( CMC-Na (Viscosity:800-1200 mPa.s) )
Catalog No. M22463 CAS No. 9004-32-4
Sodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s) is frequently used as a viscous agent, barrier, and paste agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 30 | In Stock |
|
| 1G | 41 | In Stock |
|
Biological Information
-
Product NameSodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s)
-
NoteResearch use only, not for human use.
-
Brief DescriptionSodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s) is frequently used as a viscous agent, barrier, and paste agent.
-
DescriptionSodium carboxymethyl cellulose (Viscosity:800-1200 mPa.s) is frequently used as a viscous agent, barrier, and paste agent.
-
In Vitro——
-
In Vivo——
-
SynonymsCMC-Na (Viscosity:800-1200 mPa.s)
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number9004-32-4
-
Formula Weight——
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Oxyberberine
Oxyberberine is isolated from the methanol extract of A. mexicana. It has been used to study the SW480 human colon cancer cell line.
-
BRD-K98645985
BRD-K98645985 is a BAF (mammalian SWI/SNF) transcriptional repression inhibitor with an EC50 of ~2.37 μM. BRD-K98645985 binds ARID1A-specific BAF complexes, prevents nucleosomal positioning, and potently reverses HIV-1 latency, without T cell activation or toxicity.
-
Lyoniside
Lyoniside and saracoside are cytotoxic to promastigotes and intracellular amastigotes, they demonstrate strong anti-leishmanial efficacies in BALB/c mice model of leishmaniasis, suggests that these two compounds potential anti-leishmanial candidates.
Cart
sales@molnova.com